Comparison of crystal structures and effects of Co substitution in a new member of Fe-1111 superconductor family AeFeAsF(Ae = Ca and Sr): a possible candidate for higher Tc superconductor

We refined crystal structures of newly found members of the Fe-1111 superconductor family, CaFe\_{1-x}Co\_{x}AsF and SrFe\_{1-x}Co\_{x}AsF (x = 0, 0.06, 0.12) by powder synchrotron X-ray diffraction analysis. The tetragonal to orthorhombic phase transitions were observed at ~120 K for unsubstituted CaFeAsF and at ~180 K for unsubstituted SrFeAsF, the transition temperatures agreeing with kinks observed in temperature-dependent resistivity curves. Although the transition temperature decreases, the structural phase transitions were observed below 100 K in both samples of x = 0.06, and finally they were suppressed in the doping level of x = 0.12. The refined structures reveal that distortions of the FeAs4 tetrahedron from the regular tetrahedron likely originate from mismatches in atomic radii among the constituent elements. In this system, the enlarged FeAs4 tetrahedron resulting from larger radius of Sr than that of Ca is flattened along a-b plane, whereas the smaller radius of Ca makes the tetrahedron closer to regular one, and their characteristic shapes are further enhanced by Co substitution. These results suggest that the CaFeAsF compound is a promising candidate for higher-Tc superconductor.Comment: 17 pages, 8 figures, 2 tables, Supplementary information is included at the end of the documen

Glycemic Control and Insulin Improve Muscle Mass and Gait Speed in Type 2 Diabetes: The MUSCLES-DM Study

Ken Sugimoto, Hiroshi Ikegami, Yasunori Takata, Tomohiro Katsuya, Masahiro Fukuda, Hiroshi Akasaka, Yasuharu Tabara, Haruhiko Osawa, Yoshihisa Hiromine, Hiromi Rakugi, Glycemic Control and Insulin Improve Muscle Mass and Gait Speed in Type 2 Diabetes: The MUSCLES-DM Study, Journal of the American Medical Directors Association, 2020, https://doi.org/10.1016/j.jamda.2020.11.003

Insulin receptor cleavage induced by estrogen impairs insulin signaling

Introduction: Soluble insulin receptor (sIR), which is the ectodomain of insulin receptor (IR), is present in human plasma. Plasma sIR levels are positively correlated with blood glucose levels and negatively correlated with insulin sensitivity. An in vitro model of IR cleavage shows that extracellular calpain 2 directly cleaves IR, which generates sIR, and sequential cleavage of the IRβ subunit by γ-secretase impairs insulin signaling in a glucose concentration-dependent manner. Nevertheless, sIR levels vary among subjects with normal glucose levels. Research design and methods: We examined sIR levels of pregnant women throughout gestation. Using an in vitro model, we also investigated the molecular mechanisms of IR cleavage induced by estradiol. Results: In pregnant women, sIR levels were positively correlated with estrogen levels and significantly increased at late pregnancy independent of glucose levels. Using an in vitro model, estrogen elicited IR cleavage and impaired cellular insulin signaling. Estradiol-induced IR cleavage was inhibited by targeting of calpain 2 and γ-secretase. Estrogen exerted these biological effects via G protein-coupled estrogen receptor, and its selective ligand upregulated calpain 2 expression and promoted exosome secretion, which significantly increased extracellular calpain 2. Simultaneous stimulation of estrogen and high glucose levels had a synergic effect on IR cleavage. Metformin prevented calpain 2 release in exosomes and restored insulin signaling impaired by estrogen. Conclusions: Estradiol-induced IR cleavage causes cellular insulin resistance, and its molecular mechanisms are shared with those by high glucose levels. sIR levels at late pregnancy are significantly elevated along with estrogen levels. Therefore, estradiol-induced IR cleavage is preserved in pregnant women and could be part of the etiology of insulin resistance in gestational diabetes mellitus and overt diabetes during pregnancy

A at Single Nucleotide Polymorphism-358 Is Required for G at -420 to Confer the Highest Plasma Resistin in the General Japanese Population

Insulin resistance is a feature of type 2 diabetes. Resistin, secreted from adipocytes, causes insulin resistance in mice. We previously reported that the G/G genotype of single nucleotide polymorphism (SNP) at −420 (rs1862513) in the human resistin gene (RETN) increased susceptibility to type 2 diabetes by enhancing its promoter activity. Plasma resistin was highest in Japanese subjects with G/G genotype, followed by C/G, and C/C. In this study, we cross-sectionally analyzed plasma resistin and SNPs in the RETN region in 2,019 community-dwelling Japanese subjects. Plasma resistin was associated with SNP-638 (rs34861192), SNP-537 (rs34124816), SNP-420, SNP-358 (rs3219175), SNP+299 (rs3745367), and SNP+1263 (rs3745369) (P<10−13 in all cases). SNP-638, SNP -420, SNP-358, and SNP+157 were in the same linkage disequilibrium (LD) block. SNP-358 and SNP-638 were nearly in complete LD (r2 = 0.98), and were tightly correlated with SNP-420 (r2 = 0.50, and 0.51, respectively). The correlation between either SNP-358 (or SNP-638) or SNP-420 and plasma resistin appeared to be strong (risk alleles for high plasma resistin; A at SNP-358, r2 = 0.5224, P = 4.94×10−324; G at SNP-420, r2 = 0.2616, P = 1.71×10−133). In haplotypes determined by SNP-420 and SNP-358, the estimated frequencies for C-G, G-A, and G-G were 0.6700, 0.2005, and 0.1284, respectively, and C-A was rare (0.0011), suggesting that subjects with A at −358, generally had G at −420. This G-A haplotype conferred the highest plasma resistin (8.24 ng/ml difference/allele compared to C-G, P<0.0001). In THP-1 cells, the RETN promoter with the G-A haplotype showed the highest activity. Nuclear proteins specifically recognized one base difference at SNP-358, but not at SNP-638. Therefore, A at -358 is required for G at −420 to confer the highest plasma resistin in the general Japanese population. In Caucasians, the association between SNP-420 and plasma resistin is not strong, and A at −358 may not exist, suggesting that SNP-358 could explain this ethnic difference

Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus

AIMS/INTRODUCTION: Hyperglycemia is a risk factor for sarcopenia when comparing individuals with and without diabetes. However, no studies have investigated whether the findings could be extrapolated to patients with diabetes with relatively higher glycemic levels. Here, we aimed to clarify whether glycemic control was associated with sarcopenia in patients with type 2 diabetes. MATERIALS AND METHODS: Study participants consisted of patients with type 2 diabetes (n = 746, the average age was 69.9 years) and an older general population (n = 2, 067, the average age was 68.2 years). Sarcopenia was defined as weak grip strength or slow usual gait speed and low skeletal mass index. RESULTS: Among patients with type 2 diabetes, 52 were diagnosed as having sarcopenia. The frequency of sarcopenia increased linearly with glycated hemoglobin (HbA1c) level, particularly in lean individuals (HbA1c <6.5%, 7.0%, ≥6.5% and <7.0%: 18.5%; HbA1c ≥7.0% and <8.0%: 20.3%; HbA1c ≥8.0%: 26.7%). The linear association was independent of major covariates, including anthropometric factors and duration of diabetes (HbA1c <6.5%: reference; ≥6.5% and <7.0%: odds ratio [OR] 4.38, P = 0.030; HbA1c ≥7.0% and <8.0%: 4.29, P = 0.024; HbA1c ≥8.0%: 7.82, P = 0.003). HbA1c level was specifically associated with low skeletal mass index (HbA1c ≥8.0%: OR 5.42, P < 0.001) rather than weak grip strength (OR 1.89, P = 0.058) or slow gait speed (OR 1.13, P = 0.672). No significant association was observed in the general population with a better glycemic profile. CONCLUSIONS: Poor glycemic control in patients with diabetes was associated with low muscle mass

Modelling of greenhouse gases and related species in the Arctic environment

Numerical modelling of greenhouse gases (GHGs) has become an integral part for understanding amplitude and variability in their concentrations and sources/sinks, atmospheric transport and climate implication. Carbon dioxide (CO2), methane (CH4) and nitrous oxide (N2O) are the three major species studied in the Arctic Green Network of Excellence (GRENE), a programme funded by the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT). In addition some of the ozone depleting substances, e.g., methyl chloroform (CH3CCl3), have provided strong constrain on the global mean abundance of hydroxyl (OH) radical and its relative abundance in the northern and southern hemispheres (NH/SH OH ratio; Patra et al., 2014). Being the main destroyer of many of the GHGs (e.g., CH4, hydrofluorocarbons), accurate quantification of OH was needed for estimation of CH4 sink in the troposphere, and thus the sources on the Earth’s surface by inverse modelling (Patra et al., 2016). OH is also contributes to chemical production of CO2, up to ~50% of land/ocean sink. The modellers are also required to verify the accuracy of model transport using tracers of short (e.g., 222Rn with 3.8 days) and long (SF6 with 3200 yrs) lifetimes. For understanding of the carbon cycle science, analyses of oxygen (O2/N2) variability are also conducted. List of chemistry-transport models (CTMs) participating in the Arctic GRENE programme are given Table 1.O08-05, Final Symposium on GRENE-Arctic Climate Change Research Project = GRENE北極気候変動研究事業研究成果報告会 (3-4 March, 2016, National Institute for Japanese Language and Linguistics, Tachikawa, Japan